ISSN Portal
The Keepers Registry (preservation)
SHERPA/RoMEO (access policies)
OncoTargets and Therapy
container_bwceqkynfng2tiizopvmfu34zy
Dove Medical Press
Homepage URLs
https://www.dovepress.com/oncotargets-and-therapy-journal |
Example Publications
Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report
Meshaal Alanzi, Mohammad Abu-Tineh, Lajos Szabados, MZ Sharaf Eldean, Sali Alatasi, Ruba Y Taha, Sarah A Elkourashy
2023
|
OncoTargets and Therapy
doi:10.2147/ott.s394193 pmcid:PMC9961566
Ineffectiveness of Crizotinib in a Non-Small-Cell Lung Cancer with Novel ALK- LIMS1 Fusion: A Case Report
Junmei Shi, Zhaohui Jia, Zhiguo Zhou, Liyan Zhao, Qingju Meng, Yibing Liu
2023
|
OncoTargets and Therapy
doi:10.2147/ott.s388962 pmcid:PMC9942507
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
Estela Pineda, Marta Domenech, Ainhoa Hernández, Silvia Comas, Carmen Balaña
2023
|
OncoTargets and Therapy
doi:10.2147/ott.s366371 pmcid:PMC9884437
Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report
Xiangming Zhang, Kai Ni, Huijun Chen
2023
|
OncoTargets and Therapy
doi:10.2147/ott.s393165 pmcid:PMC9884431
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report
Kazuhito Misawa, Shinji Nakamichi, Hiroki Iida, Atsuhiro Nagano, Erika Mikami, Takehiro Tozuka, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Kaoru Kubota, Hiroki Yamaguchi, Masahiro Seike
2023
|
OncoTargets and Therapy
doi:10.2147/ott.s398375 pmcid:PMC9884059
7,270
Known Releases
Open Access Publication
Preservation Summary [more]
7,036 | preserved and accessble (bright) | |
140 | preserved, inaccessible (dark) | |
94 | no known preservation |
Lookup Links